Answers are grounded in this paper and cite their sources.
Purpose: To evaluate the diagnostic performance of radiologists, with and without an artificial intelligence tool, at a tertiary cancer centre. Methods: The institutional review board considered this study at a tertiary cancer centre as a quality improvement project. Pre-biopsy ultrasound images of thyroid nodules obtained by a single interventional radiologist between July 2023 and April 2025 were retrospectively evaluated by five subspecialised diagnostic radiologists independently for thyroid imaging reporting and data system assessment, first without and then with the artificial intelligence tool. Standalone artificial intelligence assessments were also recorded. Diagnostic performance metrics were assessed, including conditional sensitivity, conditional specificity and conditional area under the curve. Results: Ninety nodules from 73 patients (50/73, 68%, female; mean age, 56 ± 17 years) were included. Pathology and genetic testing classified 46/90 nodules (51%) as benign, 31/90 (34%) as malignant and 13/90 (14%) as indeterminate. Compared to radiologist interpretation alone, artificial intelligence assistance yielded slight improvements in conditional specificity (44% [95% confidence interval: 22%, 69%] vs 38% [95% confidence interval: 15%, 65%]), high risk predictive value (58% [95% confidence interval: 37%, 78%] vs 57% [95% confidence interval: 35%, 77%]), area under the receiver operating characteristic curve (0.78 vs 0.75), overall test yield (42% [95% confidence interval: 30%, 53%] vs 38% [95% confidence interval: 27%, 49%]) in classifying benign and malignant nodules, though not statistically significant. Conclusion: Combined radiologist and artificial intelligence tool interpretations achieved similar diagnostic performance to interpretation by radiologists alone or Koios DS Thyroid alone, demonstrating utility of artificial intelligence–assisted interpretation in a specialised cancer centre with a high prevalence of rare and aggressive thyroid and non-thyroid malignancies.
No takes yet. Share an insight, caveat, or question.
Law et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: